OMNICARBON CARDIAC VALVE PROSTHESIS

FDA Premarket Approval P830039 S011

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for the omnicarbon cardiac valve prosthesis in the additional size of 21 mm of the model 3313 (aortic) and size 25 mm of the model 3523 (mitral). The supplement requested approval of these sizes as an addition to the existing, approved (july 26, 2001; p830039/s007) product line of aortic sizes 23, 25, 27 and 29 mm, and mitral sizes 27, 29, 31, and 33 mm. The device is indicated for the replacement of malfunctioning native or prosthetic aortic and mitral valves.

DeviceOMNICARBON CARDIAC VALVE PROSTHESIS
Generic NameHeart-valve, Mechanical
ApplicantMEDICALCV, INC.
Date Received2002-05-07
Decision Date2002-10-29
PMAP830039
SupplementS011
Product CodeLWQ 
Advisory CommitteeCardiovascular
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address MEDICALCV, INC. 9725 South Robert Trail inver Grove Heights, MN 55077

Supplemental Filings

Supplement NumberDateSupplement Type
P830039Original Filing
S011 2002-05-07 Normal 180 Day Track
S010 1999-05-04 Normal 180 Day Track
S009 1998-12-08 30-day Notice
S008 1998-07-22 Real-time Process
S007 1996-10-24 Panel Track
S006 1996-09-30 Normal 180 Day Track
S005
S004
S003
S002 1988-01-25 Normal 180 Day Track
S001

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.